Stephens Kristin

Stephens Kristin is listed in filings as Chief Development Officer at Syros Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Nov 20, 2024, including sale activity. Recent filings connect the profile to Syros Pharmaceuticals, Inc. (SYRS). The current snapshot covers public activity from Nov 4, 2024 to Nov 20, 2024. Reported amounts are shown as $7.9K to $12.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.